Takeda Indonesia

Takeda Indonesia Company Introduction

Takeda Indonesia is a subsidiary of Takeda medical Company Limited, a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. I've found that The company focuses on delivering innovative medicines and vaccines to patients in Indonesia, aiming to enhance health and condition of life. But Takeda Indonesia is primarily a manufacturer. It operates a manufacturing facility in Pulogadung, Jakarta, where it produces a range of medical items and vaccines to the regional market. But In addition to manufacturing, Takeda Indonesia also functions as a distributor and trader, responsible to the sales, marketing, and distribution of its locally produced medicines as well as imported Takeda items across various therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, and plasma-derived therapies. In my experience, Classification: Manufacturer and Trader/Distributor.

Takeda Indonesia

Takeda Indonesia produces and sells a range of pharmaceutical products. While specific product availability can vary by region and evolve over time, their portfolio generally includes:

**Oncology**

* Iclusig (ponatinib)

* Ninlaro (ixazomib)

* Velcade (bortezomib)

**Gastroenterology**

* Entyvio (vedolizumab)

**Rare Diseases**

* Firazyr (icatibant)

* Takhzyro (lanadelumab)

* Vowst (fecal microbiota spores, live-L donaldson)

**Plasma-Derived Therapies**

* Albumin

* Immune Globulin (IVIG)

* Various clotting factors